We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRUGMAKERS EXAMINING IMPACT OF FDA DRUG-TRACKING PROPOSAL
DRUGMAKERS EXAMINING IMPACT OF FDA DRUG-TRACKING PROPOSAL
March 1, 2004
In an effort to address mounting concerns over counterfeiting, the FDA's Counterfeit Drug Task Force issued a final report last month urging drugmakers to adopt electronic track-and-trace technology and other authentication tools by 2007.